Lysin Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Lysin Bio General Information

Description

Devloper of antibiotics intended to provide bio-antibiotics to treat super bacteria. The company develops protein medicine based on gene recombinant technology, fermentation techniques, target material separating and purifying technology and a range of biotechnology, enabling patients to receive the best drugs to prevent bacteria.

Contact Information

Website
www.lysinbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 187, Techno 2-ro
  • Room 226, Building C, 2nd Migun Techno World
  • Daejeon, Yuseong
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 187, Techno 2-ro
  • Room 226, Building C, 2nd Migun Techno World
  • Daejeon, Yuseong
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lysin Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 11-Nov-2025 Completed Product Development
2. Accelerator/Incubator Completed Product Development
1. Seed Round 01-May-2022 Completed Product Development
To view Lysin Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Lysin Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altolan Ventures Venture Capital Minority
Daedeok Venture Partners Venture Capital Minority
IBK Changgong Accelerator/Incubator
To view Lysin Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Lysin Bio FAQs

  • When was Lysin Bio founded?

    Lysin Bio was founded in 2020.

  • Where is Lysin Bio headquartered?

    Lysin Bio is headquartered in Daejeon, South Korea.

  • What industry is Lysin Bio in?

    Lysin Bio’s primary industry is Drug Discovery.

  • Is Lysin Bio a private or public company?

    Lysin Bio is a Private company.

  • What is Lysin Bio’s current revenue?

    The current revenue for Lysin Bio is .

  • Who are Lysin Bio’s investors?

    Altolan Ventures, Daedeok Venture Partners, and IBK Changgong have invested in Lysin Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process